Analysis of Market Segments and Major Growth Areas in the Corticosteroids Industry

The corticosteroids market is rapidly evolving as new medical needs and advancements shape its trajectory. With rising health challenges worldwide and continuous innovation in pharmaceutical formulations, this sector is set to experience robust growth in the coming years. Let's explore the current market valuation, key players, emerging trends, and segment insights shaping the corticosteroids industry.

Expected Market Size and Growth Outlook for the Corticosteroids Market
The corticosteroids market is projected to expand significantly, reaching a valuation of $8.34 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 7.1% during the forecast period. The increasing global prevalence of autoimmune and respiratory diseases, along with the introduction of safer corticosteroid formulations, are central to this upward trend. Additional factors driving market expansion include the aging population worldwide, better healthcare accessibility in emerging nations, and rising investments in corticosteroid-related research. Key developments anticipated in this period involve more targeted steroid formulations, therapies that emphasize lower doses and shorter treatment durations, an increase in the use of topical and inhaled corticosteroids, combination drugs with bronchodilators, and a broader application in acute respiratory care settings.

Download a free sample of the corticosteroids market report:
https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Top Companies Dominating the Corticosteroids Market Landscape
A number of leading pharmaceutical companies steer the corticosteroids market globally. Some of the prominent names include McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, and Hikma Pharmaceuticals plc.

Strengthening Market Positions Through Strategic Acquisitions
In June 2024, Sun Pharmaceutical Industries Ltd., a specialty generic pharmaceutical company based in India, acquired Taro Pharmaceutical Industries Ltd., an Israel-based research-driven pharmaceutical manufacturer known for its corticosteroid products. The acquisition, for an undisclosed sum, is aimed at reinforcing Sun Pharma's foothold in the pharmaceutical space, particularly in off-patent, prescription, and over-the-counter drug segments. This move is expected to bolster Sun Pharma's portfolio and market influence in key therapeutic areas.

View the full corticosteroids market report:
https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Trends Creating New Opportunities in the Corticosteroids Market
Pharmaceutical leaders are increasingly focusing on developing innovative corticosteroid-based products to capture larger customer segments, boost sales, and drive revenue growth. One notable category gaining attention is rescue medications, which provide rapid relief for acute symptoms or sudden flare-ups of chronic conditions.

A prime example is AstraZeneca plc's FDA approval of Airsupra in January 2023. This UK-based company introduced Airsupra, a fixed-dose combination rescue inhaler containing albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid with anti-inflammatory effects. This pressurized metered-dose inhaler (pMDI) is the first of its kind and is indicated for adults aged 18 and over. It can be used on an as-needed basis to alleviate bronchoconstriction and reduce the risk of asthma exacerbations. Available in the United States, this product is being further developed through collaboration between AstraZeneca and Avillion.

Detailed Segmentation of the Corticosteroids Market
The corticosteroids market is segmented comprehensively in this report to provide a clear understanding of different areas:

1) By Product Type:
- Glucocorticoids
- Mineralocorticoids

2) By Application:
- Skin Allergies
- Rheumatology Indications
- Endocrinology
- Acute Respiratory Diseases
- Other Applications

3) By End User:
- Hospitals
- Clinics
- Research Institutes
- Other End Users

Further subdivision within glucocorticoids includes specific drugs such as Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, and other glucocorticoids. Mineralocorticoid subcategories comprise Fludrocortisone, Aldosterone, and other mineralocorticoids.

This detailed segmentation highlights the diversity within the corticosteroids market and its wide-ranging therapeutic applications across healthcare settings.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.